Products

Latest press and releases on orthopaedic products, devices, implants and services.

An evolving anatomy conserving stabilization method which uses a small midline incision, interbody fusion (IBF), and a divergent, corticocancellous screw trajectory has been gaining in popularity. This increase in popularity can be attributed to numerous factors, including: 1. Stabilization quality: The use of interbody fusion provides excellent anterior column support and the screw trajectory engages more cortical bone than traditional approaches. 2. Decompressive access: The procedure is done through a midline (laminectomy) exposure and provides excellent visualization of all neural anatomy. 3. Anatomy conservation: Construct assembly can be completed within the confines of a typical laminectomy exposure; no additional exposure for the fusion construct is required.

Read more ...

Four weeks after giving birth to twins, Tokoya Proctor cradled a three-dimensional model of her sons in her hands. Made of plastic from an MRI scan taken when Proctor was 16 weeks pregnant, it captured an exact likeness of the fetuses drowsing in her womb. Her twins were hugging, conjoined along the chest and abdomen. They shared a liver. One twin's heart poked into his brother's chest, wrapped in a common membrane with the second heart. "It was amazing," she says. "It was a work of art." For Proctor's medical team, it was much more: a guide to the high-risk separation surgery ahead.

Read more ...

Onlay and inlay designs of implants for isolated patellofemoral disease demonstrated similar functional improvements and better pain scores. Patients who received the inlay implant, however, did not show osteoarthritis progression in a study published in Knee Surgery, Sports Traumatology, Arthroscopythat compared the inlay-style Arthrosurface HemiCap Wave implant with traditional onlay-style implants for this indication. In the onlay group, 53% of patients demonstrated osteoarthritis (OA) progression in other parts of their knees, a condition that may lead to the need to revise a patellofemoral (PF) implant with total knee arthroplasty, according to a press release from Arthrosurface. “I believe our patients’ remarkable success stories and their unmatched return to high-demand activities reignited interest in treating isolated PF joint disease within the orthopedic community…,” Steven Ek, president and CEO of Arthrosurface, stated in the release.

Read more ...

Ossis Ltd, which uses 3D printing technology to custom design titanium implants for patients with severely damaged bones and joints, is expanding to the UK. The Christchurch-based company this year doubled monthly sales of the implants to four or five across New Zealand and Australia. It's now in talks with a UK distributor to enter that market in the next few months, giving it a springboard to Europe, the second-largest market after the US. "We'd be hoping to sell upwards of 100 a year easily in the UK market over time," said general manager Madeleine Martin. The company will eventually look to place staff on the ground in Europe to liaise with the orthopaedic surgeons who make the call on whether to use the products, she said.

Read more ...

Monday, 7 September 2015, 10:08 am Article: BusinessDesk Ossis targets UK market to expand sales of 3D titaniumimplants By Fiona Rotherham Sept. 4 (BusinessDesk)- Ossis Ltd, which uses 3D printing technology to customdesign titanium implants for patients with severely damagedbones and joints, is expanding outside of Australasia to theUK. The Christchurch-based company this year doubledmonthly sales of the implants to four or five across NewZealand and Australia. It's now in talks with a UKdistributor to enter that market in the next few months,giving it a springboard to Europe, the second-largest marketafter the US. "We’d be hoping to sell upwards of 100 ayear easily in the UK market over time,” said generalmanager Madeleine Martin.

Read more ...

Tweet Exactech (NASDAQ:EXAC) was upgraded by Zacks from a “sell” rating to a “hold” rating in a note issued to investors on Friday, MarketBeat Ratings reports. According to Zacks, “Exactech, Inc. develops, manufactures, markets and distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its principal products include its knee and hip replacement systems. Exactech, Inc. is headquartered in Gainesville, Florida. “ In other Exactech news, SVP Bruce E.

Read more ...

1. The company is still focused on three major growth strategies: therapy innovation, globalization and economic value. "We believe our three growth strategies are the right ones to achieve long-term growth and the resulting diversification, differentiated approach and competitive advantages will enable us to deliver on our baseline financial expectations," he said. 2. Medtronic recently formed a joint venture giving the company controlling interest in its largest distributor in Saudi Arabia, which is expected to deliver incremental revenue and improved margins in country. The company saw notable improvements in China, India and Russia. 3. The CMS proposed bundled payment initiatives mandate for hip and knee replacements could have an impact on the company's business.

Read more ...

NovaBone Products LLC (NBP) has released a new form of the synthetic bone graft, NovaBone Putty® (bone graft substitute). "Surgeons now have a synthetic that handles more easily," said Arthur Wotiz, CEO of NovaBone Products.  "NovaBone Bioactive Synthetic Graft is the only bone graft substitute that has been proven to signal, recruit, proliferate and differentiate osteoblasts.

Read more ...

Orthopedic surgeon Dr. Evan D. Collins recently launched one of the most significant joint reconstruction studies in years - producing results that will change the way physicians approach small joint arthroplasty. Utilizing a new implant and refined technique, Dr. Collins reduced the recovery time of patients undergoing joint reconstruction at the base of the thumb (CMC Arthroplasty) by over four months.

Read more ...

curasan AG presented innovative medical products from the Cerasorb® umbrella brand at the 57th annual congress of the Association of South-German Orthopaedic Surgeons (Vereinigung Süddeutscher Orthopäden e. V.) - Report on experiences with the use of Cerasorb® M during revision operations to correct acetabular cup loosening in the hip joint: use of Cerasorb® M for filling of defects successful in 30 older patients - Low risk of infection documented

Read more ...

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!